Parametric Portfolio Associates’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$229M Sell
3,022,070
-10
-0% -$792 0.12% 151
2021
Q4
$258M Buy
3,022,080
+46,929
+2% +$3.66M 0.13% 132
2021
Q3
$225M Sell
2,975,151
-163,525
-5% -$13M 0.13% 139
2021
Q2
$255M Buy
3,138,676
+91,139
+3% +$7.45M 0.14% 133
2021
Q1
$240M Buy
3,047,537
+130,334
+4% +$10.2M 0.14% 127
2020
Q4
$249M Buy
2,917,203
+80,094
+3% +$6.62M 0.16% 112
2020
Q3
$219M Sell
2,837,109
-64,818
-2% -$4.94M 0.16% 107
2020
Q2
$213M Sell
2,901,927
-11,161
-0.4% -$793K 0.16% 108
2020
Q1
$193M Buy
2,913,088
+209,619
+8% +$14.8M 0.18% 105
2019
Q4
$186M Sell
2,703,469
-139,895
-5% -$9.54M 0.14% 137
2019
Q3
$209M Buy
2,843,364
+39,818
+1% +$2.89M 0.17% 106
2019
Q2
$201M Buy
2,803,546
+43,950
+2% +$3.12M 0.17% 106
2019
Q1
$189M Sell
2,759,596
-218,966
-7% -$14.1M 0.16% 110
2018
Q4
$177M Buy
2,978,562
+58,098
+2% +$3.63M 0.18% 99
2018
Q3
$196M Buy
2,920,464
+5,265
+0.2% +$351K 0.17% 101
2018
Q2
$189M Sell
2,915,199
-265,021
-8% -$17.3M 0.18% 100
2018
Q1
$228M Buy
3,180,220
+105,747
+3% +$7.61M 0.22% 70
2017
Q4
$232M Sell
3,074,473
-33,149
-1% -$2.42M 0.23% 71
2017
Q3
$226M Buy
3,107,622
+76,235
+3% +$5.49M 0.25% 67
2017
Q2
$225M Buy
3,031,387
+1,292,531
+74% +$96M 0.27% 60
2017
Q1
$127M Sell
1,738,856
-490,610
-22% -$34.3M 0.19% 78
2016
Q4
$146M Buy
2,229,466
+300,584
+16% +$20.6M 0.2% 81
2016
Q3
$143M Buy
1,928,882
+116,527
+6% +$8.61M 0.21% 75
2016
Q2
$133M Buy
1,812,355
+127,878
+8% +$9.11M 0.21% 74
2016
Q1
$119M Buy
1,684,477
+35,043
+2% +$2.33M 0.19% 88
2015
Q4
$110M Buy
1,649,434
+101,161
+7% +$6.73M 0.19% 99
2015
Q3
$98.3M Buy
1,548,273
+2,919
+0.2% +$191K 0.19% 102
2015
Q2
$101M Buy
1,545,354
+53,917
+4% +$3.66M 0.2% 91
2015
Q1
$103M Buy
1,491,437
+40,541
+3% +$2.8M 0.21% 81
2014
Q4
$100M Buy
1,450,896
+56,293
+4% +$3.8M 0.21% 85
2014
Q3
$91M Sell
1,394,603
-67,875
-5% -$4.48M 0.2% 92
2014
Q2
$99.7M Buy
1,462,478
+26,542
+2% +$1.78M 0.22% 78
2014
Q1
$93.1M Buy
1,435,936
+30,205
+2% +$1.9M 0.22% 82
2013
Q4
$91.7M Buy
1,405,731
+44,471
+3% +$2.85M 0.22% 79
2013
Q3
$80.7M Buy
1,361,260
+14,265
+1% +$845K 0.22% 79
2013
Q2
$77.2M Buy
+1,346,995
New +$80M 0.23% 74

Other funds holding CL

Parametric Portfolio Associates's CL Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Colgate-Palmolive (CL) stake by 0% in Q1 2022, selling an estimated $792 and leaving 3,022,070 shares worth $229M. The position accounts for 0.12% of the portfolio, ranked #151.

Parametric Portfolio Associates first reported a position in CL in Q2 2013 and has held it in 36 quarters since. The position peaked at $258M in Q4 2021. 1,632 funds tracked by Wall St. Rank hold CL as of Q1 2022.

  • Parametric Portfolio Associates held 3,022,070 shares of Colgate-Palmolive worth $229M as of Q1 2022.
  • Parametric Portfolio Associates sold 10 Colgate-Palmolive shares in Q1 2022, an estimated $792.
  • Colgate-Palmolive made up 0.12% of Parametric Portfolio Associates's portfolio in Q1 2022, its #151 holding.
  • Parametric Portfolio Associates first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 36 quarters since.
  • Parametric Portfolio Associates's Colgate-Palmolive position peaked at $258M in Q4 2021.
  • 1,632 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.